Vancouver, BC – The Western Region Society of Nuclear Medicine (WRSNM) will honor Dr. Jeremie Calais, MD, MSc, from the University of California Los Angeles (UCLA) with the presentation of their Sanjiv Sam Gambhir, MD, PhD Distinguished Scientist Award.
The Award will be presented virtually to Dr. Calais at the 2023 WRSNM Annual Meeting, November 3-5, 2023 at the Pan Pacific Hotel in Vancouver, British Columbia, Canada. The Award is given annually at the WRSNM Meeting to an individual who has made significant contributions to the Clinical Science of Nuclear Medicine or Molecular Imaging.
Dr. Calais is an Associate Professor of Nuclear Medicine and Theranostics in the Department of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA). He is the director of the UCLA Theranostics Program and the Director of the Clinical Research Program of the Ahmanson Translational Theranostics Division. Dr. Calais earned his medical degree and Master of Science degree at the University of Paris, France.
Calais is a nuclear medicine physician specializing in cancer imaging and theranostics. He conducts investigator-initiated and industry-sponsored clinical trials of targeted molecular imaging and therapy. His goal is to improve the outcome of patients with cancer through theranostic approaches and the application of knowledge gained from preclinical models and clinical studies.
Dr. Calais is also an Associate Editor of The Journal of Nuclear Medicine, a Board Member of the Correlative Imaging Council (CIC) of the SNMMI, a Committee Member of the Prostate Theranostics and Imaging Centre of Excellence (ProsTIC), Melbourne and an Advisory Board Member of the Oncidium Foundation, Belgium.